Core Laboratories (NYSE:CLB - Get Free Report) is expected to be issuing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect the company to post earnings of $0.1618 per share and revenue of $131.87 million for the quarter. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Individuals can find conference call details on the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.
Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%. The company had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. During the same quarter last year, the company posted $0.19 earnings per share. The business's quarterly revenue was down 4.3% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $0.56 EPS for the current fiscal year and $0.79 EPS for the next fiscal year.
Core Laboratories Stock Down 0.8%
CLB opened at $10.06 on Wednesday. The business's 50-day simple moving average is $11.36 and its 200-day simple moving average is $12.60. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.55 and a current ratio of 2.12. Core Laboratories has a one year low of $9.48 and a one year high of $20.36. The stock has a market capitalization of $461.78 million, a P/E ratio of 17.97, a price-to-earnings-growth ratio of 2.03 and a beta of 1.14.
Core Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Monday, August 10th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Monday, August 10th. Core Laboratories's dividend payout ratio is presently 7.14%.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on CLB. Wall Street Zen raised Core Laboratories from a "sell" rating to a "hold" rating in a report on Saturday, August 1st. Johnson Rice raised Core Laboratories from a "hold" rating to a "buy" rating and set a $21.00 target price for the company in a report on Thursday, August 13th. Finally, Weiss Ratings downgraded shares of Core Laboratories from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, October 2nd. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Core Laboratories presently has an average rating of "Hold" and an average price target of $21.00.
Get Our Latest Stock Report on Core Laboratories
Insider Transactions at Core Laboratories
In other news, CEO Lawrence Bruno bought 5,000 shares of the firm's stock in a transaction that occurred on Friday, July 31st. The shares were purchased at an average price of $10.78 per share, for a total transaction of $53,900.00. Following the completion of the transaction, the chief executive officer owned 262,438 shares in the company, valued at $2,829,081.64. The trade was a 1.94% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.26% of the company's stock.
About Core Laboratories
(
Get Free Report)
Core Laboratories N.V. NYSE: CLB is a global provider of proprietary and patented reservoir description and production enhancement services to the energy industry. Its customers include oil and natural gas exploration and production companies, national oil companies, and independent operators.
The company's reservoir description activities include the analysis of rock and fluid samples, core and special core analysis, petrophysical services, geological and reservoir modeling, and laboratory measurements used to evaluate hydrocarbon reservoirs and improve field development decisions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.